| scholarly article | Q13442814 |
| P2093 | author name string | S D Finkelstein | |
| R L Hamilton | |||
| R Sposto | |||
| Children's Cancer Group | |||
| A J Yates | |||
| J L Finlay | |||
| E J Holmes | |||
| I F Pollack | |||
| J Burnham | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7404-7407 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort | |
| P478 | volume | 61 |
| Q33237311 | Advances in treatment of pediatric brain tumors |
| Q33790042 | Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison |
| Q34196216 | Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group |
| Q36145387 | Apoptotic markers for primary brain tumor prognosis |
| Q43422757 | Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas |
| Q34203979 | Biology, genetics and imaging of glial cell tumours |
| Q35799783 | Capturing the molecular and biological diversity of high-grade astrocytoma in genetically engineered mouse models |
| Q36048214 | Clinical and molecular characteristics of congenital glioblastoma |
| Q36585123 | Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies |
| Q92370079 | DIVERSet JAG Compounds Inhibit Topoisomerase II and Are Effective Against Adult and Pediatric High-Grade Gliomas |
| Q33861173 | Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma |
| Q50089322 | Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location |
| Q34044498 | GRIM-19 Expression and Function in Human Gliomas |
| Q34722504 | Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas |
| Q34458930 | IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group |
| Q36908344 | IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK |
| Q35070545 | Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945. |
| Q54498867 | Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes. |
| Q53427862 | Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas. |
| Q33990951 | Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease |
| Q36010103 | Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas |
| Q35972863 | Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group |
| Q34734398 | MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas |
| Q26785952 | Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment |
| Q35918862 | Molecular analysis of pediatric brain tumors |
| Q36623358 | Molecular genetics of pediatric central nervous system tumors |
| Q36021571 | Molecular pathogenesis of childhood brain tumors |
| Q36695883 | Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage |
| Q36047046 | Novel cell lines established from pediatric brain tumors. |
| Q39943645 | Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. |
| Q37729676 | Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge |
| Q38013990 | Paediatric and adult malignant glioma: close relatives or distant cousins? |
| Q38233425 | Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism? |
| Q36644898 | Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy |
| Q39208269 | Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. |
| Q36273006 | Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches |
| Q33847771 | Pediatric low-grade gliomas: how modern biology reshapes the clinical field |
| Q34364959 | Pediatric primary intramedullary spinal cord glioblastoma |
| Q38074880 | Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies |
| Q41138860 | Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study |
| Q37665337 | Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis |
| Q43154532 | Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas |
| Q49093936 | Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression |
| Q34514088 | Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification |
| Q37565322 | TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma. |
| Q36800148 | Targeted therapy for BRAFV600E malignant astrocytoma. |
| Q33751426 | The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma |
| Q37904503 | Treatment of high-grade glioma in children and adolescents |
Search more.